Solifenacin
Drugs For Urinary Frequency and Incontinence
- Drug class
- Drugs For Urinary Frequency and Incontinence
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 123
Overview
Solifenacin is an active pharmaceutical ingredient in the Drugs For Urinary Frequency and Incontinence group (G04BD). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 113 | May 15, 2026 |
| CA Canada | Health Canada | 8 | February 10, 2026 |
| US United States | FDA | 2 | January 28, 2026 |
GBUnited Kingdom· MHRA
113 products
Uses
Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.
How to take
CACanada· Health Canada
8 products
Uses
…………....
How to take
USUnited States· FDA
2 products
Uses
1 INDICATIONS AND USAGE Solifenacin succinate tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin succinate tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency ( 1 ).
How to take
Drug interactions
Known interactions involving Solifenacin. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 428. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL317500148 · revised August 13, 2024
- [2]Health Canada (DPD) · 02403595 · revised February 10, 2026
- [3]FDA DailyMed · 010c0657-c907-47… · revised January 28, 2026 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.